Facilities



Vevo LAZR high resolution Ultrasound imaging

  • Photoacoustic
  • Contrast
  • Anatomical
  • Vascular
  • Hypoxia
  • SPF Facility

Life imaging > Ultra sound scanner

The imaging platform features a Photoacoustic imager coupled with high resolution ultrasound (Vevo LAZR - VisualSonics). This imaging modality offers new prospects for explorations, particularly in oncology and more specifically in the field of tumor hypoxia. Photoacoustics (PA) is a recent imaging modality combining the advantages of ultrasound (resolution) and photon imaging (sensitivity) to provide anatomical, functional and molecular data. One of its main applications is the in vivo quantification of saturation of hemoglobin with oxygen (SO2). It is a way to map SO2 in real time, due to differences in optical absorption between oxygenated and deoxygenated hemoglobin. This technique thus makes it possible to document and characterize the oxygenation status of tumors during their development. It is also possible to use exogenous agents sensitive to the laser (methylene blue, ICG, NanoRods ...) in order to study their biodistribution or to target biological phenomena (molecular imaging). Contrast ultrasound is another mode of the device that uses IV bubbles injected to study the vascularization of tissues and tumors but it is also possible to target biomarkers with specific targeted μbubbles.

Contact Task Facility Manager (TFM)

04 69 85 61 98

Depending structure

CRCL

28 Rue Laennec

69008 Lyon
04 72 68 19 30

infos : Website

The Cancer Research Center of Lyon (CRCL, UMR Inserm 1052 CNRS 5286 - Centre Léon Bérard) is a research structure affiliated with the University Claude Bernard Lyon 1, the national health and research bodies (Inserm and CNRS), the Léon Bérard Comprehensive Cancer Centre (CLB) and with the Lyon University Hospitals (HCL) as clinical partners. The CRCL was officially created in January 2011 and its 5-year contract was recently renewed for the 2016-2020 period. It comprises 24 teams, totalling over 480 members, including 138 researchers and lecturers. The CRCL aims at increasing its international visibility and the attractiveness of the Lyon cancer research cluster, at facilitating the transfer of knowledge from fundamental cancer research to clinical applications in oncology, and at developing teaching and training in oncology. 

One of the main goals of the CRCL is to support the development of strong translatio

Other's Laboratory/Plateforme

Email


* Your email is sent directly to the contact, a copy of this email will be sent to This email address is being protected from spambots. You need JavaScript enabled to view it..

Depending structure : CRCL
Federation :

SFR Santé Lyon-Est et SFR Biosciences


Lab tutorship :

Lyon 1 ; INSERM ; CNRS ; CLB


28 rue Laënnec
Centre Léon Bérard, Cheney A' N1
69373 Lyon Cedex 08

infos : Website

Full support :
Continuous education :
Access with light support :
Open to academic :
Open to industry :


MEANS


Steering committee

Composition :

  • en cours de constitution

MEANS Team

  • S. Gavarini : CTµ, FRAMA/ICL/BioEnvis – Coordinateur (stephane.gavarini@univ-lyon1.fr)
  • E. Jeanneau : CDHL, ICL (erwann.jeanneau@univ-lyon1.fr)
  • P. Pittet : NanoLyon, FRAMA et ICL (Patrick.Pittet@univ-lyon1.fr)
  • J. Briolay : DTamb, BioEnvis (jerome.briolay@univ-lyon1.fr)
  • C. Oger : PRABI, BioEnvis (Christine.Oger@univ-lyon1.fr)
  • C. Pera : Modélisation et Sc. numérique Fr FLMSN (christophe.pera@univ-lyon1.fr)
  • R. Chiriac : Analyse thermique, ICL (rodica.chiriac@univ-lyon1.fr)
  • Anne Baudouin (CCRMN)
  • Virginie Gueguen-Chaignon (PSF)
  • Brigitte Prevel (ILMTECH)